Old Web
English
Sign In
Acemap
>
Paper
>
1256P Capmatinib safety update in MET dysregulated NSCLC from the GEOMETRY mono-1 trial
1256P Capmatinib safety update in MET dysregulated NSCLC from the GEOMETRY mono-1 trial
2021
Rebecca S. Heist
Edward B. Garon
H. J. M. Groen
D.S.W. Tan
O Tanriverdi
Anna Robeva
S. Le-Mouhaer
Mariana Carbini
A. Chassot Agostinho
Juergen Wolf
Keywords:
Capmatinib
Oncology
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]